Protein-bound crotonaldehyde accumulates in the spinal cord of superoxide dismutase-1 mutation-associated familial amyotrophic lateral sclerosis and its transgenic mouse model

Neuropathology

Volumn 27, Issue 1, 2007, Pages 49-61

  Shibata, Noriyuki ^a   Kawaguchi, Motoko ^a   Uchida, Koji ^b   Kakita, Akiyoshi ^c   Takahashi, Hitoshi ^c   Nakano, Ryoichi ^d   Fujimura, Harutoshi ^e   Sakoda, Saburo ^f   Ihara, Yuetsu ^g   Nobukuni, Keigo ^g   Takehisa, Yasushi ^h   Kuroda, Shigetoshi ^h   Kokubo, Yasumasa ⁱ   Kuzuhara, Shigeki ⁱ   Honma, Taku ^j   Mochizuki, Yoko ^j,m   Mizutani, Tomohiko ^j   Yamada, Satoshi ^k   Toi, Sono ^a   Sasaki, Shoichi ^a   Iwata, Makoto ^a   Hirano, Asao ^l   Yamamoto, Tomoko ^a   Kato, Yoichiro ^a   Sawada, Tatsuo ^a   Kobayashi, Makio ^a   more..

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d Sato Neurology Clinic   (Japan)

^e TONEYAMA NATIONAL HOSPITAL   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Department of Internal Medicine   (Japan)

^h OKAYAMA UNIVERSITY   (Japan)

ⁱ MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k NOF Corporation   (Japan)

^l MONTEFIORE MEDICAL CENTER   (United States)

^m National Hospital Organization   (Japan)

more..

Author keywords

Amyotrophic lateral sclerosis; Crotonaldehyde; Lipid peroxidation; Superoxide dismutase 1; Transgenic mouse model

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CROTONALDEHYDE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL COUNT; CELL SWELLING; CELL VACUOLE; CONTROLLED STUDY; DISEASE COURSE; EXPERIMENTAL MODEL; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MOTONEURON; MOUSE; NERVE FIBER; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SPHEROID CELL; SPINAL CORD; SPINAL CORD VENTRAL HORN; STATISTICAL SIGNIFICANCE; TRANSGENIC MOUSE;

ADULT; AGED; ALDEHYDES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MOTOR NEURONS; MUTATION; NEUROGLIA; OXIDATIVE STRESS; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 33846430885     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2006.00746.x     Document Type: Article

References (55)

1. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine, 3rd edn. London: Oxford, 1999.
2. Lenaz G, Bovina C, D'Aurelio M et al. Role of mitochondria in oxidative stress and ageing. Ann NY Acad Sci 2002; 959: 199-213.
3. Harman D. The free radical theory of aging. Antioxid Redox Signal 2003; 5: 557-561.
4. Inoue M, Sato EF, Nishikawa M et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003; 10: 2495-2505.
5. Mujahid A, Yoshiki Y, Akiba Y, Toyomizu M. Superoxide radical production in chicken skeletal muscle induced by acute heat stress. Poult Sci 2005; 84: 307-314.
6. Beal MF. Mitochondria take canter stage in aging and neurodegeneration. Ann Neurol 2005; 58: 495-505.
7. Esterbauer H, Schauer RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
8. Leonarduzzi G, Arkan M, Başaǧa H et al. Lipid peroxidation products in cell signaling. Free Radic Biol Med 2000; 28: 1370-1378.
9. Uchida K. Role of reactive aldehyde in cardiovascular diseases. Free Radic Biol Med 2000; 28: 1685-1696.
10. Miyata T, De Strihou van Y, Kurokawa K, Bayness J. Alterations in nonenzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in lon-term uremic complications. Kidney Int 1999; 55: 389-399.
11. International Agency for Research on Cancer (IARC) (eds). Crotonaldehyde. In: Dry Cleaning, Some Chlorinated Solvents and Other Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 63. Lyon: IARC, 1995; 373-391.
12. Wang MY, Chung FL, Hecht SS. Identification of crotonaldehyde as a hepatic microsomal metabolite formed by α-hydroxylation of the carcinogen N-nitrosopyrrolidone. Chem Res Toxicol 1988; 1: 28-31.
13. Ichibashi K, Osawa T, Toyokuni S, Uchida K. Endogenous formation of protein adducts with carcinogenic aldehydes. J Biol Chem 2001; 276: 23903-23913.
14. Chung FL, Tanaka T, Hecht SS. Induction of liver tumors in F344 rats by crotonaldehyde. Cancer Res 1986; 46: 1285-1289.
15. Wang M, McIntee EJ, Cheng G et al. Identification of paraldol-deoxyguanosine adducts in DNA reacted with crotonaldehyde. Chem Res Toxicol 2000; 13: 1065-1074.
16. Swash M. Clinical features and diagnosis of amyotrophic lateral sclerosis. In: Brown RH Jr, Meininger V, Swash M (eds). Amyotrophic Lateral Sclerosis, 1st edn. London: Martin Dunitz, 2000; 3-30.
17. Shaw PJ, Ince PG, Falkous G et al. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691-695.
18. Fitzmaurice PS, Shaw IC, Kleiner HE et al. Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve 1996; 19: 797-798.
19. Ferrante RJ, Browne SE, Shinobu LA et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064-2074.
20. Shibata N, Yamada S, Uchida K et al. Accumulation of protein-bound 4-hydroxy-2-hexenal in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Brain Res 2004; 1019: 170-177.
21. Shibata N, Nagai R, Uchida K et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917: 97-104.
22. Shibata N, Hirano A, Yamamoto T et al. Superoxide dismutase-1 mutation-related neurotoxicity in familial amyotrophic lateral sclerosis. ALS 2000; 1: 143-161.
23. Gurney ME, Pu H, Chiu AY et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772-1775.
24. Takahashi H, Makifuchi T, Nakano R et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn superoxide dismutase gene. Acta Neuropathol 1994; 88: 185-188.
25. Shibata N, Hirano A, Kobayashi M et al. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol 1996; 55: 481-490.
26. Inoue K, Fujimura H, Ogawa Y et al. Familial amyotrophic lateral sclerosis with a point mutation (G37R) of the superoxide dismutase 1 gene: a clinicopathological study. ALS 2002; 3: 244-247.
27. Mochizuki Y, Mizutani T, Nakano R et al. Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with an H43R mutation in Cu/Zn superoxide dismutase (in Japanese with English abstract). Rinsho Shinkeigaku 2003; 43: 491-495.
28. Tan CF, Piao YS, Hayashi S et al. Familial amyotrophic lateral sclerosis with bulbar onset and a novel Asp101Tyr Cu/Zn superoxide dismutase gene mutation. Acta Neuropathol 2004; 108: 332-336.
29. Fujimura H, Sumi T, Fukada K et al. Stability of mutant superoxide dismutase-1 and incidence of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis (in Japanese with English abstract). Clin Neurol 2002; 42: 1283.
30. Kokubo Y, Kuzuhara S, Narita Y et al. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Arch Neurol 1999; 56: 1506-1508.
31. Takehisa Y, Ujike H, Ishizu H et al. Familial amyotrophic lateral sclerosis with a novel Leu126Ser mutation in the copper/zinc superoxide dismutase gene showing mild clinical features and Lewy body-like hyaline inclusions. Arch Neurol 2001; 58: 736-741.
32. Kadekawa J, Fujimura H, Ogawa Y et al. A clinicopathological study of a patient with familial amyotrophic lateral sclerosis associated with a two base pair deletion in the copper/zinc superoxide dismutase (SOD1) gene. Acta Neuropathol 1997; 94: 617-622.
33. Wong PC, Pardo AC, Borchelt DR et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105-1116.
34. Vardimon L, Fox LE, Cohen-Kupiec R et al. Expression of v-Src in embryonic neuronal retina alters cell adhesion, inhibits histogenesis, and prevents induction of glutamine synthase. Mol Cell Biol 1991; 11: 5275-5284.
35. McLendon RE, Bigner DD. Immunohistochemistry of the glial fibrillary acidic protein: basic and applied considerations. Brain Pathol 1994; 4: 221-228.
36. Pulford KA, Sipos A, Cordell JL et al. Distribution of the CD68 macrophage/myeloid associated antigen. Int Immunol 1990; 2: 973-980.
37. Springer TA. Adhesion receptors ofnthe immune system. Nature 1990; 346: 425-434.
38. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995; 676: 25-40.
39. Maihöfner C, Probst-Cousin S, Bergmann M et al. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Eur J Neurosci 2003; 18: 1527-1534.
40. Sasaki S, Shibata N, Komori T, Iwata M. iNOS and nitrotyrosine immunoreactivity in amyotrophic lateral sclerosis. Neurosci Lett 2000; 291: 44-48.
41. Sillevis Smitt PA, Mulder TP, Verspaget HW et al. Metallothionein in amyotrophic lateral sclerosis. Biol Signals 1994; 3: 193-197.
42. Shibata N, Asayama K, Hirano A, Kobayashi M. Immunohistochemical study on superoxide dismutases in spinal cords from autopsied patients with amyotrophic lateral sclerosis. Dev Neurosci 1996; 18: 492-498.
43. Sparaco M, Gaeta LM, Tozzi G et al. Protein glutathionylation in human central nervous system: potential role in redox regulation of neuronal defense against free radicals. J Neurosci Res 2005; 83: 256-263.
44. Shinpo K, Kikuchi H, Sasaki H et al. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Res 2000; 861: 151-159.
45. Hirano A, Inoue K. Early pathological changes of amyotrophic lateral sclerosis. Electron microscopic study of chromatolysis, spheroid and Bunina bodies (in Japanese with English abstract). Neurol Med 1980; 13: 148-160.
46. Martin LJ, Kaiser A, Price AC. Motor neuron degeneration after sciatic nerve avulsion in adult rat evolves with oxidative stress and is apoptosis. J Neurobiol 1999; 40: 185-201.
47. Gordon T, Hegedus J, Tam SL. Adaptive and maladaptive motor axonal sprouting in ageing and motoneuron disease. Neurol Res 2004; 26: 174-185.
48. Reaume AG, Elliott JL, Hoffman EK et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43-47.
49. G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci 2003; 4: 16.
50. Wataya T, Nunomura A, Smith MA et al. High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal. J Biol Chem 2002; 277: 4644-4648.
51. Liu Q, Smith LA, Avilla J et al. Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations. Free Radic Biol Med 2005; 38: 746-754.
52. Barbeito LH, Pehar M, Cassina P et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Rev 2004; 47: 263-274.
53. Zhao W, Xie W, Le W et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol 2004; 63: 964-977.
54. Tortarolo M, Veglianese P, Calvaresi N et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 2003; 23: 180-192.
55. Mhatre M, Floyd RA, Hensley K. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimers Dis 2004; 6: 147-157.